Literature DB >> 23430905

Lymphatic edema in congenital disorders of glycosylation.

Ruud Hj Verstegen1, Miranda Theodore, Hans van de Klerk, Eva Morava.   

Abstract

Congenital disorders of glycosylation (CDG) are a group of metabolic disorders caused by deficient protein glycosylation. PMM2-CDG, the most common CDG, is caused by phosphomannomutase (PMM) deficiency. Clinical symptoms often include neurological involvement in addition to dysmorphic features, failure to thrive, cardiac failure, renal, and endocrine abnormalities. To our knowledge, lymphatic edema in CDG has not been reported. We present two cases of lymphatic edema in PMM2-CDG patients. The first patient was noted to have a larger right leg circumference at two years. Ultrasound investigations did not reveal any obvious vascular or lymphatic malformation. The swelling increased in size over time. At 12 years, lymphoscintigraphy revealed decreased lymphatic draining in both legs, which was more profound in the right leg. The second patient was treated for pulmonary stenosis at age 2 months. Postoperative, the patient suffered from protein-losing enteropathy, hypothyroidism, recurrent bacterial infections, and bilateral lymphatic edema. General condition improved after thyroxin treatment and albumin infusions; however, the bilateral pedal and leg edema remained unresolved. Contrast studies of the lymphatic system showed bilateral hypoplasia distal to the knees. Although both children had secondary factors worsening lymphatic edema in PMM2-CDG, hypoalbuminemia, recurrent infections, cardiac failure, and endocrine abnormalities could not fully explain the clinical features. The additional factors were treated successfully but the therapy did not resolve the lymphatic edema. Based on the abnormal imaging studies of the lymphatic system, we propose that lymphatic vessel hypoplasia is the major cause for lymphatic edema in our patients with PMM2-CDG.

Entities:  

Year:  2011        PMID: 23430905      PMCID: PMC3509901          DOI: 10.1007/8904_2011_82

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  12 in total

Review 1.  Structure, function, and molecular control of the skin lymphatic system.

Authors:  M Skobe; M Detmar
Journal:  J Investig Dermatol Symp Proc       Date:  2000-12

2.  Pretibial myxoedema associated with Hashimoto's thyroiditis.

Authors:  S P Cannavò; F Borgia; M Vaccaro; F Guarneri; E Magliolo; B Guarneri
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-11       Impact factor: 6.166

3.  Myxoedematous infiltrate of the forehead in treated hypothyroidism.

Authors:  J C Forgie; A S Highet; S A Kelly
Journal:  Clin Exp Dermatol       Date:  1994-03       Impact factor: 3.470

Review 4.  Congenital disorders of glycosylation.

Authors:  Jaak Jaeken
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

5.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.

Authors:  P de Lonlay; N Seta; S Barrot; B Chabrol; V Drouin; B M Gabriel; H Journel; M Kretz; J Laurent; M Le Merrer; A Leroy; D Pedespan; P Sarda; N Villeneuve; J Schmitz; E van Schaftingen; G Matthijs; J Jaeken; C Korner; A Munnich; J M Saudubray; V Cormier-Daire
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

6.  Pretibial myxedema as the initial manifestation of Graves' disease.

Authors:  S Georgala; A C Katoulis; C Georgala; E C Katoulis; E Hatziolou; N G Stavrianeas
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-07       Impact factor: 6.166

7.  Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic.

Authors:  Gerard Damen; Hans de Klerk; Jan Huijmans; Jan den Hollander; Maarten Sinaasappel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

Review 8.  The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).

Authors:  Stephanie Grünewald
Journal:  Biochim Biophys Acta       Date:  2009-01-14

9.  Pericardial and abdominal fluid accumulation in congenital disorder of glycosylation type Ia.

Authors:  Gerben Truin; Mailys Guillard; Dirk J Lefeber; Jolanta Sykut-Cegielska; Maciej Adamowicz; Esther Hoppenreijs; Rob C A Sengers; Ron A Wevers; Eva Morava
Journal:  Mol Genet Metab       Date:  2008-06-20       Impact factor: 4.797

Review 10.  Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy.

Authors:  S Modi; A W B Stanton; P S Mortimer; J R Levick
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

View more
  3 in total

1.  ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines.

Authors:  Daniah Albokhari; Bobby G Ng; Alis Guberinic; Earnest James Paul Daniel; Nicole M Engelhardt; Rita Barone; Agata Fiumara; Livia Garavelli; Gabriele Trimarchi; Lynne Wolfe; Kimiyo M Raymond; Eva Morava; Miao He; Hudson H Freeze; Christina Lam; Andrew C Edmondson
Journal:  J Inherit Metab Dis       Date:  2022-06-30       Impact factor: 4.750

2.  Vascular ring anomaly in a patient with phosphomannomutase 2 deficiency: A case report and review of the literature.

Authors:  Zhen Qian; Jef Van den Eynde; Stephane Heymans; Luc Mertens; Eva Morava
Journal:  JIMD Rep       Date:  2020-08-19

Review 3.  Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Authors:  Maria Monticelli; Tiago Ferro; Jaak Jaeken; Vanessa Dos Reis Ferreira; Paula A Videira
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.